About Azienda Ospedaliera Ospedali Riuniti Marche Nord, Presidio Ospedaliero San Salvatore
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Azienda Ospedaliera Ospedali Riuniti Marche Nord, Presidio Ospedaliero San Salvatore
During the past decade, Azienda Ospedaliera Ospedali Riuniti Marche Nord, Presidio Ospedaliero San Salvatore conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Paclitaxel and Radiation Therapy With or Without Trastuzumab in Treating Patients Who Have Undergone Surgery for Bladder Cancer
2005-07-26
2022-05-20
Completed
70
Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer
2006-12-13
2011-12-15
Completed
46
Dasatinib in Treating Patients With Recurrent Glioblastoma Multiforme or Gliosarcoma
2007-01-24
2018-09-04
Completed
64
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
2008-11-10
Active, not recruiting
2,014
Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer
2009-03-23
Unknown status
601
Temozolomide and Radiation Therapy With or Without Bevacizumab in Treating Patients With Newly Diagnosed Glioblastoma
2009-04-15
2013-03-17
Completed
637
Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy
2009-11-01
2014-11-01
Completed
242
Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer
2009-09-01
2025-10-01
Active, not recruiting
1,538
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Azienda Ospedaliera Ospedali Riuniti Marche Nord, Presidio Ospedaliero San Salvatore
According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliera Ospedali Riuniti Marche Nord, Presidio Ospedaliero San Salvatore" are
"Cholangiocarcinoma" (1 trials), "Colon Cancer Liver Metastasis" (1 trials), "Gastric Adenocarcinoma" (1 trials), "Gastroesophageal Junction Adenocarcinoma" (1 trials) and "Liver Cell Carcinoma Non-resectable" (1 trials). Many other conditions were trialed in "Azienda Ospedaliera Ospedali Riuniti Marche Nord, Presidio Ospedaliero San Salvatore" in a lesser frequency.
Clinical Trials Intervention Types at Azienda Ospedaliera Ospedali Riuniti Marche Nord, Presidio Ospedaliero San Salvatore
Most popular intervention types in "Azienda Ospedaliera Ospedali Riuniti Marche Nord, Presidio Ospedaliero San Salvatore" are "Drug" (5 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Capecitabine" (1 trials), "Docetaxel" (1 trials), "Doxorubicin" (1 trials), "FOLFIRI+Bevacizumab" (1 trials) and "FOLFOX" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Azienda Ospedaliera Ospedali Riuniti Marche Nord, Presidio Ospedaliero San Salvatore
The vast majority of trials in "Azienda Ospedaliera Ospedali Riuniti Marche Nord, Presidio Ospedaliero San Salvatore" are
7 trials for "All" genders.
Clinical Trials Status at Azienda Ospedaliera Ospedali Riuniti Marche Nord, Presidio Ospedaliero San Salvatore
Currently, there are NaN active trials in "Azienda Ospedaliera Ospedali Riuniti Marche Nord, Presidio Ospedaliero San Salvatore".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Azienda Ospedaliera Ospedali Riuniti Marche Nord, Presidio Ospedaliero San Salvatore,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Azienda Ospedaliera Ospedali Riuniti Marche Nord, Presidio Ospedaliero San Salvatore, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".